Cathie Wood’s ARK ETF made several notable moves on Monday, November 2nd, 2026, reflecting a strategic shift in its investment approach. The firm sold 341,024 shares of Personal, Inc., totaling $5,394,999, continuing its trend of reducing exposure to the company. This sale follows previous reductions in recent weeks, signaling a potential loss of confidence in Personal, Inc.
On the buying side, ARK acquired 24,790 shares of Coinbase Global, Inc., worth $3,558,356, spread across multiple ETFs. This purchase underscores ARK’s ongoing interest in the cryptocurrency exchange sector. Additionally, ARK increased its stake in Twist Bioscience Corporation, buying 26,262 shares valued at $4,012,308, indicating optimism in the biotech company’s growth potential.
ARK also expanded its holdings in Pacific Biosciences of California, Inc., purchasing 61,988 shares for $1,614,808. This move aligns with ARK’s focus on genomics and biotechnology. Other trades included sales of Bullish and Tempus AI, Inc., alongside purchases in Circle Internet Group, Inc., Robinhood Markets, Inc., and several biotech firms.
These transactions highlight ARK’s dynamic investment strategy, balancing reductions in certain sectors while reinforcing positions in biotechnology and cryptocurrency. Investors will be watching closely to see how these moves align with broader market trends and ARK’s long-term vision.